is atezolizumab a targeted therapy?
Atezolizumab Approved for Initial Treatment of Metastatic Lung Cancer. Atezolizumab works by targeting the immune checkpoint protein PD-L1 on cancer cells. Credit: Adapted from Onco Targets Ther 2017. doi: 10.2147/OTT.